Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?

Summary by The Motley Fool
Key PointsSales of Regeneron Pharmaceuticals' Eylea have declined over the past few quarters due to competition.However, the company launched a new formulation of the medicine that just earned another label expansion.Between the new version of Eylea and Regeneron's pipeline work, the future still looks bright. 10 stocks we like better than Regeneron Pharmaceuticals › Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been …

1 Articles

The Motley FoolThe Motley Fool
Lean Left

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?

Key PointsSales of Regeneron Pharmaceuticals' Eylea have declined over the past few quarters due to competition.However, the company launched a new formulation of the medicine that just earned another label expansion.Between the new version of Eylea and Regeneron's pipeline work, the future still looks bright. 10 stocks we like better than Regeneron Pharmaceuticals › Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech giant, have been …

·Alexandria, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Monday, December 1, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Tarrytown icon

Tarrytown

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal